BG
QGEN icon

Bellevue Group’s Qiagen QGEN Stock Holding History

Bellevue Group’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-243
Closed -$9.73K – 166
2026
Q1 		$9.73K Buy
+243
New +$11.5K ﹤0.01% 155
2020
Q2 		– Sell
-87,327
Closed -$3.85M – 222
2020
Q1 		$3.85M Sell
87,327
-64,360
-42% -$2.51M 0.07% 118
2019
Q4 		$5.44M Sell
151,687
-450,872
-75% -$16.8M 0.09% 111
2019
Q3 		$21.1M Sell
602,559
-99,558
-14% -$3.83M 0.39% 55
2019
Q2 		$30.2M Buy
702,117
+120,069
+21% +$4.97M 0.52% 49
2019
Q1 		$25.1M Buy
582,048
+171,537
+42% +$6.9M 1.38% 19
2018
Q4 		$15M Buy
410,511
+283,963
+224% +$10.5M 0.99% 32
2018
Q3 		$5.08M Buy
126,548
+54,085
+75% +$2.16M 0.32% 72
2018
Q2 		$2.78M Buy
+72,463
New +$2.67M 0.24% 76
2018
Q1 		– Sell
-53,387
Closed -$1.75M – 131
2017
Q4 		$1.75M Sell
53,387
-4,716
-8% -$163K 0.18% 87
2017
Q3 		$1.94M Sell
58,103
-16,817
-22% -$579K 0.2% 81
2017
Q2 		$2.66M Buy
+74,920
New +$2.53M 0.32% 72

Other funds holding QGEN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bellevue Group's QGEN Position: Q2 2026 in Review

Bellevue Group sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 243 shares — an estimated $9.73K sold.

Bellevue Group first reported a position in QGEN in Q2 2017 and held it in 12 quarters. The position peaked at $30.2M in Q2 2019. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Bellevue Group reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • Bellevue Group sold 243 Qiagen shares in Q2 2026, an estimated $9.73K.
  • Bellevue Group first reported a position in Qiagen in Q2 2017 and held it in 12 quarters.
  • Bellevue Group's Qiagen position peaked at $30.2M in Q2 2019.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.